- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Low or intermediate risk prostate cancer
Total 264146 results
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; Celgene CorporationCompleted
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
University of California, San FranciscoCompletedProstate Cancer | Nonmalignant NeoplasmUnited States
-
The Vaccine CompanyUnknownMyelodysplastic SyndromesUnited States
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
H. Lee Moffitt Cancer Center and Research InstituteTrod Medical, US,LLCCompleted
-
Eisai Inc.CompletedMyelodysplastic SyndromeUnited States
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Southwest Oncology GroupCompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerProstate CancerUnited States, South Africa
-
Trans Tasman Radiation Oncology GroupCompletedNasopharyngeal Cancer | Anal Cancer | Intermediate Risk Prostate Cancer | Prostate Cancer (Post Prostatectomy)Australia
-
Johnson & Johnson Pharmaceutical Research & Development...Centocor Ortho Biotech Services, L.L.C.Terminated
-
Centre Francois BaclesseTerminatedProstate Cancer With Intermediate RiskFrance
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
Fondazione Italiana Sindromi Mielodisplastiche-ETSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteTerminated
-
Sheba Medical CenterUnknown
-
VA Puget Sound Health Care SystemSchiffler Cancer CenterUnknown
-
University of Lausanne HospitalsNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
Mayo ClinicNot yet recruitingStage III Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Advanced Prostate AdenocarcinomaUnited States
-
PharmaEssentiaNot yet recruitingPrimary Myelofibrosis | Myeloproliferative Neoplasm
-
Samsung Medical CenterRecruitingHigh Risk Prostate CarcinomaKorea, Republic of
-
Maria Sklodowska-Curie National Research Institute...Not yet recruiting
-
Zachary ZumstegNot yet recruitingCarcinoma | Oropharyngeal CancerUnited States
-
Fujian Medical University Union HospitalRecruitingUrinary Bladder Neoplasms | Treatment Outcome | Neoplasm Recurrence, Local | Multicenter Study | Immunotherapy, Active | BCG VaccineChina
-
Regina Elena Cancer InstituteRecruiting
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI)Not yet recruiting
-
European Association of Urology Research FoundationNational Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University... and other collaboratorsNot yet recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingCervical Cancer | Cervix Cancer
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingAdult With Intermediate Low or Mid Rectal AdenocarcinomaFrance
-
Adam S. Kibel, MDNational Cancer Institute (NCI)RecruitingProstate Cancer | Polygenic Risk ScoreUnited States
-
University Hospital, EssenBristol-Myers Squibb; Advanced Accelerator ApplicationsNot yet recruitingVery High Risk Prostate CarcinomaGermany
-
Mayo ClinicRecruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
Eli Lilly and CompanyRecruitingOverweight and ObesityUnited States, Australia, Italy, Hungary, Netherlands, Canada, France, Spain, United Kingdom, Germany, Argentina, Czechia, Israel, Austria, Belgium, Greece, Turkey, Mexico, Romania, Brazil, India, Slovakia, Poland, Puerto Rico, Denmark
-
Ivan de Kouchkovsky, MDNot yet recruitingProstate Cancer | High Risk Prostate CarcinomaUnited States
-
Mayo ClinicRecruitingProstate Adenocarcinoma | Oligometastatic Prostate CarcinomaUnited States
-
Andrea DeCensiHerbert Irving Comprehensive Cancer Center; Breast Cancer Research Foundation; Istituto Europeo di Oncologia and other collaboratorsNot yet recruiting
-
University of Texas Southwestern Medical CenterRefleXion MedicalNot yet recruiting
-
Unidade Local De Saúde Do Norte AlentejanoNOVA Medical SchoolRecruiting
-
Chinese PLA General HospitalNot yet recruitingPapillary Thyroid Cancer
-
AOP Orphan Pharmaceuticals AGGCP-Service International Ltd. & Co. KG; ANOVA CRO s.r.o.; PharmaLex Belgium; Aixial...RecruitingPulmonary Arterial HypertensionAustria, Spain, France, Germany, Italy, Czechia, Hungary, Poland, Portugal, Romania
-
IRCCS Sacro Cuore Don Calabria di NegrarNot yet recruiting
-
European Institute of OncologyFondazione Umberto Veronesi; IceCure Medical Ltd.Recruiting
-
University Hospital TuebingenRecruitingCervical Cancer | HPV InfectionGermany
-
Cancer Research AntwerpBayer; Veracyte, Inc.Recruiting
-
Martini-Klinik am UKE GmbHUniversitätsklinikum Hamburg-EppendorfRecruitingProspective Trial: Myocardial Injury After Noncardiac Surgery (MINS) Following Radical ProstatectomyMyocardial InjuryGermany
-
M.D. Anderson Cancer CenterRecruitingMantle Cell LymphomaUnited States
-
National Cancer Center, KoreaSeoul National University Hospital; Seoul National University Bundang Hospital and other collaboratorsNot yet recruitingPapillary Thyroid Carcinoma | Thyroid CancerKorea, Republic of
-
Fondazione del Piemonte per l'OncologiaSan Luigi Gonzaga Hospital; Epidemiology and Screening Unit - CPO, Turin, ItalyNot yet recruiting
-
Virginia Commonwealth UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingProstate Cancer | Supportive CareUnited States
-
University of BernSpitalzentrum BielNot yet recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Low-riskSwitzerland